Clinical trial Services
Profil is a full-service CRO focused on early phase clinical trials in diabetes and obesity.
See how Profil can support you in the clinical development of diabetes treatments.
We are dedicated to supporting the development of new, sustainable medical intervention strategies to improve the treatment and quality of life of patients affected by obesity, cardiometabolic disease, prediabetes and diabetes mellitus. Our expert scientists stand ready to partner with you and provide full-service support for the development and registration of new drugs or medical devices for the treatment of obesity, diabetes mellitus and its comorbidities.
More than 20 years of experience in diabetes research and clinical testing make us an ideal partner for glucose clamp studies, pharmacokinetic and pharmacodynamic studies, safety and tolerability studies, bioequivalence or bridging studies and more. We have a powerful portfolio of sophisticated testing methods and our ClampArt device is the most reliable and accurate glucose clamp in the world.
As a full-service CRO, we support our clients with patient recruitment, clinical trial management, clinical trial execution, data management, statistics and medical writing as well as consultations on regulatory submissions. Read on to discover more about our clinical research services.
ISO 13485:2016
|
ISO 9001:2015
|
Linnebjerg, H. et al. 2020. Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog® (Lispro) in Younger Adults and Elderly Patients with Type 1 Diabetes Mellitus: A Randomised Controlled Trial. Clinical Pharmacokinetics, 2020. Dec;59(12):1589-1599.